Pirosa, M.C.; Hess, D.; Krasniqi, F.; Novak, U.; Mach, N.; Zenz, T.; Holer, L.; Cascione, L.; Cannas, E.; Rinaldi, A.;
et al. A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma—SAKK 66/18 Trial. Cancers 2026, 18, 1764.
https://doi.org/10.3390/cancers18111764
AMA Style
Pirosa MC, Hess D, Krasniqi F, Novak U, Mach N, Zenz T, Holer L, Cascione L, Cannas E, Rinaldi A,
et al. A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma—SAKK 66/18 Trial. Cancers. 2026; 18(11):1764.
https://doi.org/10.3390/cancers18111764
Chicago/Turabian Style
Pirosa, Maria Cristina, Dagmar Hess, Fatime Krasniqi, Urban Novak, Nicolas Mach, Thorsten Zenz, Lisa Holer, Luciano Cascione, Eleonora Cannas, Andrea Rinaldi,
and et al. 2026. "A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma—SAKK 66/18 Trial" Cancers 18, no. 11: 1764.
https://doi.org/10.3390/cancers18111764
APA Style
Pirosa, M. C., Hess, D., Krasniqi, F., Novak, U., Mach, N., Zenz, T., Holer, L., Cascione, L., Cannas, E., Rinaldi, A., Schär, S., Zucca, E., Bertoni, F., & Stathis, A., on behalf of the Swiss Group for Clinical Cancer Research SAKK.
(2026). A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma—SAKK 66/18 Trial. Cancers, 18(11), 1764.
https://doi.org/10.3390/cancers18111764
